SMAD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.044400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.629600E-01
Normal-vs-Stage2
3.074600E-01
Normal-vs-Stage3
7.040400E-02
Normal-vs-Stage4
9.837800E-01
Stage1-vs-Stage2
8.739800E-01
Stage1-vs-Stage3
2.242400E-01
Stage1-vs-Stage4
3.414000E-01
Stage2-vs-Stage3
1.992050E-01
Stage2-vs-Stage4
2.307000E-01
Stage3-vs-Stage4
1.513970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.785800E-01
Normal-vs-AfricanAmerican
6.735400E-01
Normal-vs-Asian
1.073250E-01
Caucasian-vs-AfricanAmerican
4.203600E-01
Caucasian-vs-Asian
6.927900E-02
AfricanAmerican-vs-Asian
1.119230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.301000E-01
Normal-vs-Female
4.098800E-01
Male-vs-Female
1.220970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.496390E-01
Normal-vs-Age(41-60Yrs)
6.178000E-01
Normal-vs-Age(61-80Yrs)
2.251200E-01
Normal-vs-Age(81-100Yrs)
1.213410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.372960E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.617800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.504800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.462100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.012100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.682000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.789500E-02
Normal-vs-Daily Drinker
2.993900E-02
Normal-vs-Weekly Drinker
4.678000E-01
Normal-vs-Occasional Drinker
6.799600E-01
Normal-vs-Social Drinker
7.294200E-01
Non Drinker-vs-Daily Drinker
7.536000E-01
Non Drinker-vs-Weekly Drinker
2.043800E-01
Non Drinker-vs-Occasional Drinker
5.135900E-03
Non Drinker-vs-Social Drinker
2.439200E-03
Daily Drinker-vs-Weekly Drinker
1.151800E-01
Daily Drinker-vs-Occasional Drinker
6.359700E-03
Daily Drinker-vs-Social Drinker
3.104800E-03
Weekly Drinker-vs-Occasional Drinker
4.728400E-01
Weekly Drinker-vs-Social Drinker
3.871600E-01
Occasional Drinker-vs-Social Drinker
8.593000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.693800E-01
Normal-vs-Grade 2
1.532610E-01
Normal-vs-Grade 3
1.315420E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.028200E-01
Grade 1-vs-Grade 3
2.317200E-01
Grade 1-vs-Grade 4
3.693800E-01
Grade 2-vs-Grade 3
6.861200E-01
Grade 2-vs-Grade 4
1.532610E-01
Grade 3-vs-Grade 4
1.315420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.603820E-01
Normal-vs-NonDiabetic
2.389600E-01
Diabetic-vs-NonDiabetic
3.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.907970E-01
Normal-vs-NoPancreatitis
2.378000E-01
Pancreatitis-vs-NoPancreatitis
9.187400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.541800E-01
Normal-vs-N1
3.532400E-01
N0-vs-N1
3.667600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.251600E-01
Normal-vs-TP53-NonMutant
4.155600E-01
TP53-Mutant-vs-TP53-NonMutant
5.588600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
